A detailed history of Charles Schwab Investment Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 402,565 shares of PRCT stock, worth $39.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
402,565
Previous 355,900 13.11%
Holding current value
$39.2 Million
Previous $21.7 Million 48.33%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.31 - $84.99 $2.63 Million - $3.97 Million
46,665 Added 13.11%
402,565 $32.2 Million
Q2 2024

Aug 12, 2024

BUY
$45.73 - $69.19 $668,069 - $1.01 Million
14,609 Added 4.28%
355,900 $21.7 Million
Q1 2024

May 08, 2024

BUY
$40.38 - $50.75 $249,306 - $313,330
6,174 Added 1.84%
341,291 $16.9 Million
Q4 2023

Feb 06, 2024

BUY
$24.89 - $43.41 $345,174 - $602,009
13,868 Added 4.32%
335,117 $14 Million
Q3 2023

Nov 08, 2023

BUY
$30.02 - $38.81 $2.09 Million - $2.7 Million
69,525 Added 27.62%
321,249 $10.5 Million
Q2 2023

Aug 09, 2023

BUY
$26.7 - $37.02 $682,345 - $946,083
25,556 Added 11.3%
251,724 $8.9 Million
Q1 2023

May 11, 2023

SELL
$26.64 - $39.74 $24,348 - $36,322
-914 Reduced 0.4%
226,168 $6.42 Million
Q4 2022

Feb 13, 2023

BUY
$38.78 - $46.78 $228,491 - $275,627
5,892 Added 2.66%
227,082 $9.43 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $4.02 Million - $6.59 Million
130,141 Added 142.94%
221,190 $9.17 Million
Q2 2022

Aug 15, 2022

BUY
$29.23 - $44.45 $1.16 Million - $1.76 Million
39,658 Added 77.17%
91,049 $2.98 Million
Q1 2022

May 13, 2022

BUY
$16.89 - $35.74 $20,369 - $43,102
1,206 Added 2.4%
51,391 $1.8 Million
Q4 2021

Feb 11, 2022

BUY
$24.6 - $46.29 $1.23 Million - $2.32 Million
50,185 New
50,185 $1.26 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.34B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.